Cipla is currently trading at Rs. 559.40, up by 0.30 points or 0.05% from its previous closing of Rs. 559.10 on the BSE.
The scrip opened at Rs. 559.00 and has touched a high and low of Rs. 561.20 and Rs. 556.95 respectively. So far 6952 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 621.90 on 06-Feb-2017 and a 52 week low of Rs. 458.25 on 25-May-2016.
Last one week high and low of the scrip stood at Rs. 571.65 and Rs. 556.95 respectively. The current market cap of the company is Rs. 44974.33 crore.
The promoters holding in the company stood at 37.48%, while institutions and non-institutions held 36.05% and 26.47% respectively.
Credit rating agency, Credit Analysis and Research (CARE) has reaffirmed ‘A1+’ rating to the various existing short-term bank facilities of Cipla. The company is not availing long-term bank facilities and accordingly the rating for long-term bank facilities has been withdrawn.
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |